STRATA Skin Sciences, Inc. (SSKN)
USD 2.62
(-0.76%)
USD 2.62
(-0.76%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -3.38 Million USD | -137.06% |
| 2022 | 1.12 Million USD | 474.75% |
| 2021 | 1.72 Million USD | -82.42% |
| 2020 | -164.99 Thousand USD | -107.42% |
| 2019 | 1.81 Million USD | 102.27% |
| 2018 | 2.04 Million USD | 108.9% |
| 2017 | 4.53 Million USD | -476.32% |
| 2016 | 2.76 Million USD | 115.82% |
| 2015 | -12.42 Million USD | -108.29% |
| 2014 | -14.83 Million USD | 56.53% |
| 2013 | -22.94 Million USD | -5.72% |
| 2012 | -21.7 Million USD | -8.94% |
| 2011 | -19.82 Million USD | 0.2% |
| 2010 | -19.36 Million USD | -8.79% |
| 2009 | -18.13 Million USD | -1.01% |
| 2008 | -17.29 Million USD | -40.55% |
| 2007 | -11.74 Million USD | -8.05% |
| 2006 | -11.23 Million USD | -85.69% |
| 2005 | -6.23 Million USD | -107.82% |
| 2004 | -3.06 Million USD | -66.48% |
| 2003 | -1.86 Million USD | -103.5% |
| 2002 | -915 Thousand USD | 66.2% |
| 2001 | -2.7 Million USD | -48.33% |
| 2000 | -1.82 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -1.53 Million USD | 24.51% |
| 2024 Q2 | 849 Thousand USD | 217.4% |
| 2023 FY | - USD | -137.06% |
| 2023 Q1 | -1.04 Million USD | -163.57% |
| 2023 Q3 | -615 Thousand USD | -36.67% |
| 2023 Q4 | 214 Thousand USD | 134.8% |
| 2023 Q2 | -450 Thousand USD | 57.02% |
| 2022 Q1 | -893 Thousand USD | 59.41% |
| 2022 FY | - USD | 474.75% |
| 2022 Q4 | 1.64 Million USD | 162.68% |
| 2022 Q3 | 627 Thousand USD | 347.83% |
| 2022 Q2 | -253 Thousand USD | 71.67% |
| 2021 Q3 | 493 Thousand USD | -75.92% |
| 2021 Q2 | 2.04 Million USD | 236.92% |
| 2021 Q1 | -1.49 Million USD | -398.4% |
| 2021 FY | - USD | -82.42% |
| 2021 Q4 | -2.2 Million USD | -546.25% |
| 2020 Q2 | -587 Thousand USD | -445.29% |
| 2020 Q1 | 170 Thousand USD | -71.24% |
| 2020 Q3 | -271 Thousand USD | 53.83% |
| 2020 FY | - USD | -107.42% |
| 2020 Q4 | 501 Thousand USD | 284.87% |
| 2019 Q2 | 69 Thousand USD | 187.34% |
| 2019 Q4 | 591 Thousand USD | 96.35% |
| 2019 Q1 | -79 Thousand USD | -108.1% |
| 2019 Q3 | 301 Thousand USD | 336.23% |
| 2019 FY | - USD | 102.27% |
| 2018 Q4 | 975 Thousand USD | -13.02% |
| 2018 Q2 | 341 Thousand USD | 183.78% |
| 2018 Q1 | -407 Thousand USD | -502.97% |
| 2018 FY | - USD | 108.9% |
| 2018 Q3 | 1.12 Million USD | 228.74% |
| 2017 Q3 | -12.03 Million USD | -2353.0% |
| 2017 Q2 | 534 Thousand USD | -26.24% |
| 2017 Q1 | 724 Thousand USD | -64.3% |
| 2017 FY | - USD | -476.32% |
| 2017 Q4 | 101 Thousand USD | 100.84% |
| 2016 Q1 | 1.53 Million USD | 24.57% |
| 2016 Q4 | 2.02 Million USD | 62.11% |
| 2016 Q3 | 1.25 Million USD | -43.08% |
| 2016 FY | - USD | 115.82% |
| 2016 Q2 | 2.19 Million USD | 43.57% |
| 2015 Q4 | 1.22 Million USD | 116.33% |
| 2015 Q1 | -4.63 Million USD | -107.0% |
| 2015 FY | - USD | -108.29% |
| 2015 Q3 | -7.52 Million USD | -0.06% |
| 2015 Q2 | -7.52 Million USD | -62.42% |
| 2014 Q4 | -2.23 Million USD | -76.44% |
| 2014 FY | - USD | 56.53% |
| 2014 Q3 | -1.26 Million USD | -255.98% |
| 2014 Q2 | 812.94 Thousand USD | 111.16% |
| 2014 Q1 | -7.28 Million USD | -83.89% |
| 2013 Q1 | -5.96 Million USD | -4.82% |
| 2013 FY | - USD | -5.72% |
| 2013 Q4 | -3.96 Million USD | 39.06% |
| 2013 Q3 | -6.49 Million USD | 0.33% |
| 2013 Q2 | -6.51 Million USD | -9.28% |
| 2012 Q1 | -5.6 Million USD | -27.55% |
| 2012 FY | - USD | -8.94% |
| 2012 Q4 | -5.69 Million USD | -11.52% |
| 2012 Q3 | -5.1 Million USD | 3.73% |
| 2012 Q2 | -5.3 Million USD | 5.41% |
| 2011 FY | - USD | 0.2% |
| 2011 Q1 | -4.82 Million USD | 15.48% |
| 2011 Q4 | -4.39 Million USD | 26.79% |
| 2011 Q3 | -6 Million USD | -27.79% |
| 2011 Q2 | -4.69 Million USD | 2.73% |
| 2010 Q4 | -5.71 Million USD | -18.25% |
| 2010 Q1 | -4.94 Million USD | 10.17% |
| 2010 FY | - USD | -8.79% |
| 2010 Q2 | -4.47 Million USD | 9.51% |
| 2010 Q3 | -4.83 Million USD | -7.99% |
| 2009 Q4 | -5.5 Million USD | -10.04% |
| 2009 Q2 | -3.81 Million USD | 5.21% |
| 2009 Q1 | -4.02 Million USD | 6.3% |
| 2009 FY | - USD | -1.01% |
| 2009 Q3 | -5 Million USD | -31.04% |
| 2008 Q4 | -4.29 Million USD | 1.2% |
| 2008 Q3 | -4.34 Million USD | 14.26% |
| 2008 Q2 | -5.07 Million USD | -14.12% |
| 2008 Q1 | -4.44 Million USD | -29.61% |
| 2008 FY | - USD | -40.55% |
| 2007 Q4 | -3.43 Million USD | -13.95% |
| 2007 Q2 | -3.26 Million USD | -1.67% |
| 2007 FY | - USD | -8.05% |
| 2007 Q3 | -3.01 Million USD | 7.93% |
| 2007 Q1 | -3.21 Million USD | 2.65% |
| 2006 Q1 | -3.05 Million USD | -20.38% |
| 2006 Q2 | -2.97 Million USD | 2.41% |
| 2006 Q3 | -2.53 Million USD | 14.8% |
| 2006 Q4 | -3.3 Million USD | -30.17% |
| 2006 FY | - USD | -85.69% |
| 2005 Q2 | -1.27 Million USD | -3.32% |
| 2005 Q4 | -2.53 Million USD | -86.38% |
| 2005 Q3 | -1.36 Million USD | -7.03% |
| 2005 FY | - USD | -107.82% |
| 2005 Q1 | -1.23 Million USD | -5.39% |
| 2004 Q3 | -626.07 Thousand USD | 0.0% |
| 2004 Q4 | -1.16 Million USD | -86.42% |
| 2004 FY | - USD | -66.48% |
| 2003 FY | - USD | -103.5% |
| 2002 FY | - USD | 66.2% |
| 2001 FY | - USD | -48.33% |
| 2000 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 74.939% |
| Cerus Corporation | -26.53 Million USD | 87.263% |
| OrthoPediatrics Corp. | -8.38 Million USD | 59.671% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 67.793% |
| Talis Biomedical Corporation | -66.04 Million USD | 94.882% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 79.73% |
| Inogen, Inc. | -45.67 Million USD | 92.601% |
| Spectral AI, Inc. | -12.26 Million USD | 72.435% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 92.913% |
| CVRx, Inc. | -38.73 Million USD | 91.273% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 4.195% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 72.082% |
| Orthofix Medical Inc. | -86.98 Million USD | 96.114% |
| Venus Concept Inc. | -26.11 Million USD | 87.056% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 93.209% |
| Bioventus Inc. | -23.07 Million USD | 85.349% |
| BrainsWay Ltd. | -2.31 Million USD | -46.257% |
| Envoy Medical, Inc. | -18.23 Million USD | 81.467% |
| electroCore, Inc. | -17.76 Million USD | 80.968% |
| IceCure Medical Ltd | -15.25 Million USD | 77.84% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 93.206% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 79.947% |
| MaxCyte, Inc. | -44.12 Million USD | 92.34% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 71.249% |
| Nexalin Technology, Inc. | -5.69 Million USD | 40.619% |
| PAVmed Inc | -75.74 Million USD | 95.537% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 93.713% |
| RxSight, Inc. | -41.03 Million USD | 91.764% |
| Sight Sciences, Inc. | -49.41 Million USD | 93.16% |
| SI-BONE, Inc. | -34.44 Million USD | 90.188% |
| TELA Bio, Inc. | -40.63 Million USD | 91.682% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 94.202% |
| Treace Medical Concepts, Inc. | -39 Million USD | 91.335% |
| LivaNova PLC | 39.01 Million USD | 108.663% |
| 908 Devices Inc. | -34.02 Million USD | 90.066% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 96.944% |
| Nemaura Medical Inc. | -7.28 Million USD | 53.616% |
| NeuroPace, Inc. | -22.83 Million USD | 85.198% |
| LENSAR, Inc. | -8.71 Million USD | 61.212% |
| Apyx Medical Corporation | -18.11 Million USD | 81.338% |
| Cutera, Inc. | -136.56 Million USD | 97.525% |
| BioSig Technologies, Inc. | -28.15 Million USD | 87.993% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 234.34% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 83.896% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 100.881% |
| Axonics, Inc. | 7.77 Million USD | 143.473% |
| Outset Medical, Inc. | -153.78 Million USD | 97.802% |
| IRIDEX Corporation | -7.44 Million USD | 54.619% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 96.554% |
| IRadimed Corporation | 20.8 Million USD | 116.25% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 58.075% |
| INVO Bioscience, Inc. | -6.88 Million USD | 50.872% |
| Telesis Bio, Inc. | -40.49 Million USD | 91.653% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 109.216% |
| Varex Imaging Corporation | 67.2 Million USD | 105.03% |
| Quipt Home Medical Corp. | 44.07 Million USD | 107.669% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 68.905% |
| Pulmonx Corporation | -55.09 Million USD | 93.865% |
| Dynatronics Corporation | -976 Thousand USD | -246.309% |
| Modular Medical, Inc. | -17.1 Million USD | 80.237% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 76.666% |
| Semler Scientific, Inc. | 23.58 Million USD | 114.329% |
| InMode Ltd. | 196.28 Million USD | 101.722% |
| Bruker Corporation | 599 Million USD | 100.564% |
| Cytosorbents Corporation | -28.81 Million USD | 88.268% |
| DexCom, Inc. | 916.7 Million USD | 100.369% |
| Align Technology, Inc. | 799.03 Million USD | 100.423% |
| Viveve Medical, Inc. | -20.61 Million USD | 83.606% |
| ZimVie Inc. | 91.07 Million USD | 103.711% |
| Movano Inc. | -29.12 Million USD | 88.395% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 23.321% |
| Nexalin Technology, Inc. | -5.69 Million USD | 40.619% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 4.195% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 98.264% |
| Profound Medical Corp. | -27.12 Million USD | 87.538% |
| Insulet Corporation | 323.6 Million USD | 101.044% |
| enVVeno Medical Corporation | -25.01 Million USD | 86.49% |
| Surmodics, Inc. | 1.18 Million USD | 384.512% |
| iCAD, Inc. | -6.56 Million USD | 48.515% |
| Nuwellis, Inc. | -16.35 Million USD | 79.335% |
| Biotricity, Inc. | -8.82 Million USD | 61.714% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 96.51% |
| Aethlon Medical, Inc. | -11.84 Million USD | 71.475% |
| InspireMD, Inc. | -20.91 Million USD | 83.836% |
| PAVmed Inc. | -75.74 Million USD | 95.537% |
| BIOLASE, Inc. | -15.13 Million USD | 77.674% |
| Beyond Air, Inc. | -59.03 Million USD | 94.274% |
| FONAR Corporation | 28.25 Million USD | 111.964% |
| AxoGen, Inc. | -13.32 Million USD | 74.64% |
| Vivani Medical, Inc. | -26.6 Million USD | 87.297% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 113.773% |
| Inari Medical, Inc. | 7.11 Million USD | 147.519% |
| UFP Technologies, Inc. | 72.74 Million USD | 104.646% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 0.171% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 45.094% |
| Tenon Medical, Inc. | -15.52 Million USD | 78.233% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 77.859% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 91.851% |
| AdaptHealth Corp. | -171.09 Million USD | 98.024% |
| Sintx Technologies, Inc. | -6.6 Million USD | 48.788% |
| NanoVibronix, Inc. | -3.43 Million USD | 1.601% |
| Quanterix Corporation | -38.08 Million USD | 91.126% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 68.905% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 11366.667% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 98.781% |
| TransMedics Group, Inc. | -7.6 Million USD | 55.544% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 84.47% |
| NeuroMetrix, Inc. | -7.09 Million USD | 52.366% |
| Hyperfine, Inc. | -47.06 Million USD | 92.818% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 94.203% |
| Biomerica, Inc. | -5.99 Million USD | 43.601% |
| Bone Biologics Corporation | 479.57 Thousand USD | 804.795% |
| AVITA Medical, Inc. | -39.56 Million USD | 91.458% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 63.152% |
| Silk Road Medical, Inc | -45.08 Million USD | 92.502% |